Cargando…
Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Carden Jennings Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128922/ http://dx.doi.org/10.1016/j.bbmt.2017.12.076 |
| _version_ | 1783516672566493184 |
|---|---|
| author | Al Hashmi, Hani Kaloyannidis, Panayotis Kafnar, Solaf Al Harbi, Salman Shaibani, Eshrak Mokhtar, Nihad Abdulbaki, Manar Al Darweesh, Mohammed Bacal, Jenifer Apostolidis, John Anezi, Khalid Al |
| author_facet | Al Hashmi, Hani Kaloyannidis, Panayotis Kafnar, Solaf Al Harbi, Salman Shaibani, Eshrak Mokhtar, Nihad Abdulbaki, Manar Al Darweesh, Mohammed Bacal, Jenifer Apostolidis, John Anezi, Khalid Al |
| author_sort | Al Hashmi, Hani |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7128922 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Carden Jennings Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71289222020-04-08 Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy Al Hashmi, Hani Kaloyannidis, Panayotis Kafnar, Solaf Al Harbi, Salman Shaibani, Eshrak Mokhtar, Nihad Abdulbaki, Manar Al Darweesh, Mohammed Bacal, Jenifer Apostolidis, John Anezi, Khalid Al Biol Blood Marrow Transplant Article Carden Jennings Publishing 2018-03 2018-02-03 /pmc/articles/PMC7128922/ http://dx.doi.org/10.1016/j.bbmt.2017.12.076 Text en |
| spellingShingle | Article Al Hashmi, Hani Kaloyannidis, Panayotis Kafnar, Solaf Al Harbi, Salman Shaibani, Eshrak Mokhtar, Nihad Abdulbaki, Manar Al Darweesh, Mohammed Bacal, Jenifer Apostolidis, John Anezi, Khalid Al Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy |
| title | Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy |
| title_full | Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy |
| title_fullStr | Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy |
| title_full_unstemmed | Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy |
| title_short | Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy |
| title_sort | single-agent high-dose melphalan as conditioning regimen in autologous hematopoietic stem cell transplantation for hodgkin's lymphoma: safety, and long-term efficacy |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128922/ http://dx.doi.org/10.1016/j.bbmt.2017.12.076 |
| work_keys_str_mv | AT alhashmihani singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy AT kaloyannidispanayotis singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy AT kafnarsolaf singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy AT alharbisalman singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy AT shaibanieshrak singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy AT mokhtarnihad singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy AT abdulbakimanar singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy AT aldarweeshmohammed singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy AT bacaljenifer singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy AT apostolidisjohn singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy AT anezikhalidal singleagenthighdosemelphalanasconditioningregimeninautologoushematopoieticstemcelltransplantationforhodgkinslymphomasafetyandlongtermefficacy |